1. Home
  2. UFPI vs RYTM Comparison

UFPI vs RYTM Comparison

Compare UFPI & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UFP Industries Inc.

UFPI

UFP Industries Inc.

HOLD

Current Price

$96.67

Market Cap

5.2B

ML Signal

HOLD

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$86.91

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UFPI
RYTM
Founded
1955
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Forest Products
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
5.9B
IPO Year
2011
2017

Fundamental Metrics

Financial Performance
Metric
UFPI
RYTM
Price
$96.67
$86.91
Analyst Decision
Buy
Strong Buy
Analyst Count
2
14
Target Price
$102.50
$131.14
AVG Volume (30 Days)
346.6K
921.3K
Earning Date
04-29-2026
05-05-2026
Dividend Yield
1.46%
N/A
EPS Growth
N/A
28.34
EPS
5.00
N/A
Revenue
$3,941,182,000.00
N/A
Revenue This Year
$2.04
$54.90
Revenue Next Year
$5.61
$86.58
P/E Ratio
$19.24
N/A
Revenue Growth
21.62
N/A
52 Week Low
$84.82
$55.31
52 Week High
$118.00
$122.20

Technical Indicators

Market Signals
Indicator
UFPI
RYTM
Relative Strength Index (RSI) 58.30 49.38
Support Level $88.09 $84.39
Resistance Level $107.70 $93.51
Average True Range (ATR) 2.33 4.20
MACD 1.25 0.85
Stochastic Oscillator 92.38 78.12

Price Performance

Historical Comparison
UFPI
RYTM

About UFPI UFP Industries Inc.

UFP Industries Inc is a supplier of lumber to the manufactured housing industry. Today UFP Industries is a multibillion-dollar holding company with subsidiaries around the globe that serve three markets: retail, packaging and construction. Its business segments consist of UFP Retail Solutions, UFP Packaging, UFP Construction, All other and Corporate. It describes itself as an innovation company, a logistics company, a design company, an engineering and value-added product and solutions company.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Share on Social Networks: